Fundraising Fox

Vanqua Bio

Chicago, US · Founded 2019 · Delaware corporation · 11 known investors

Find your way into Vanqua Bio

464 people in our graph share verified history with the Vanqua Bio team — schools, employers, funds. One of them is your warm intro.

Liz Westhouseunlockedknows Jim Sullivan, Ph.D. · together at Northwestern University (overlapped)
×3knows the team · via AbbVie
×2knows the team · via Northwestern University
×6knows the team · via Trinity College Dublin

Founders & leadership

RS
Rand SutherlandExecutive
JSJames Sullivan
James SullivaninExecutiveJames Sullivan is an R&D executive with extensive experience in pharmaceutical and biotech development, having led over 100 compounds into clinical trials across multiple disease areas including cancer, hepatitis C, Alzheimer's disease, and inflammatory conditions. He has experience with company formation and serves as Executive Officer and Director of Vanqua Bio.

Board

JSJonathan Silverstein
Jonathan SilversteininBoard directorPartner at OrbiMed
BD
Bernard DavitianBoard director
UC
Uya ChuluunbaatarBoard director
MAMona Ashiya
Mona AshiyainBoard directorGeneral Partner at OrbiMed

Investors · 11

Also in the syndicate · 6

Eli LillyEli Lilly and CompanyLogos CapitalOmega FundsleadPontifaxSurveyor Capital

Reported raises · per SEC filings

Form D private placements

$136M disclosed across 3 rounds · 2019–2024

$45MraisedJul 2024 · 12 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jonathan SilversteinDirector
  • Rand SutherlandDirector
  • Bernard DavitianDirector
  • Uya ChuluunbaatarDirector
  • James SullivanExecutive Officer, Director
  • Mona AshiyaDirector
Offering amount
$45M
Amount sold
$45M
First sale
Feb 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$85MraisedSep 2021 · 11 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Mona AshiyaDirector
  • Viola MeehanExecutive Officer
  • Bernard DavitianDirector
  • Sara NayeemDirector
  • James SullivanExecutive Officer, Director
  • Jonathan SilversteinDirector
  • Stephen SquintoDirector
Offering amount
$85M
Amount sold
$85M
First sale
Aug 2021
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$6MraisedOct 2019 · 1 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • JONATHAN SILVERSTEINExecutive Officer, Director
  • JAMES SULLIVANExecutive Officer, Director
  • MONA ASHIYADirector
Offering amount
$18M
Amount sold
$6M
First sale
Sep 2019
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Frequently asked questions

Who are Vanqua Bio's investors?
Vanqua Bio's investors include Pontifax Venture Capital, Avoro Ventures, Casdin Capital, OrbiMed, Osage University Partners.
How much funding has Vanqua Bio raised?
Vanqua Bio has disclosed $136M raised across 3 rounds.
Where is Vanqua Bio headquartered?
Vanqua Bio is headquartered in Chicago, US.